Personal and Social-Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy.
Soohyun Nam, Sangchoon Jeon, Garrett I Ash and 8 others
PMID 39243147WHAT IT FOUND
No glucose variability results are reported. 55 adults with type 2 diabetes completed 14 days of glucose, activity, sleep and diary monitoring.
No adverse events were reported, but about 10% of glucose sensors fell off.
Key findings
01As of March 2024, 55 participants had enrolled, with mean age 61±11 years, and each completed 14 days of data collection.
02No adverse events or side effects were reported with continuous glucose monitoring or real-time lifestyle data.
03About 10% of continuous glucose monitoring sensors fell off before the 14-day completion and had to be replaced.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
No associations between sleep, physical activity, diet, emotional well-being, and glucose variability are reported. The study reports a protocol and early feasibility data, not tested intervention outcomes. Only 55 participants had enrolled as of March 2024, compared with the planned 200. Participants were English-speaking Connecticut adults with recent HbA1c 7-11% who owned a smartphone, and shift workers or untreated or uncontrolled obstructive sleep apnea were excluded. About 10% of continuous glucose monitoring sensors fell off before 14-day completion. Ecological momentary assessment responses were 80-100%.
Declared interests
The authors declared no conflicts of interest. The paper is listed as supported by NIH extramural funding.
The easy way to misread this
Do not read this as evidence that sleep, physical activity, diet, emotional well-being, or continuous glucose monitoring improve glucose variability. The paper is a protocol and reports feasibility, not associations with the planned primary outcome.